Viernes, 19 Junio 2020 13:59
Situation Report - 151 - Organización Mundial de la Salud - 19/06/2020
The hydroxychloroquine arm of the Solidarity Trial, which seeks to find an effective COVID19 treatment, is being stopped. The decision is based on evidence from the Solidarity Trial, the UK's Recovery trial and a Cochrane review of other evidence on hydroxychloroquine. Data shows that hydroxychloroquine does not result in the reduction of mortality of hospitalised COVID-19 patients, when compared with standard of care.
Publicado en
OMS/OPS/CDC
Localizar por Tema